29 related articles for article (PubMed ID: 38525896)
1. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.
Jampol LM; Glassman AR; Liu D; Aiello LP; Bressler NM; Duh EJ; Quaggin S; Wells JA; Wykoff CC;
Ophthalmology; 2018 Jul; 125(7):1054-1063. PubMed ID: 29525602
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: A network meta-analysis.
Yao J; Huang W; Gao L; Liu Y; Zhang Q; He J; Zhang L
PLoS One; 2024; 19(6):e0304283. PubMed ID: 38848379
[TBL] [Abstract][Full Text] [Related]
3. Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema.
Pichi F; Abdi A; Aljneibi S; El Ghrably I; Agarwal A; Ghazi NG
Int Ophthalmol; 2024 Jun; 44(1):275. PubMed ID: 38916818
[TBL] [Abstract][Full Text] [Related]
4. Visual outcomes following anti-VEGF therapy in patients with DME.
Panigrahi PK; Patro M
Indian J Ophthalmol; 2024 Jul; 72(Suppl 4):S718. PubMed ID: 38953138
[No Abstract] [Full Text] [Related]
5. Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.
Jampol LM; Glassman AR; Bressler NM
JAMA Ophthalmol; 2015 Sep; 133(9):983-4. PubMed ID: 26087135
[No Abstract] [Full Text] [Related]
6. Treatment Effects of Switching to Faricimab in Eyes with Diabetic Macular Edema Refractory to Aflibercept.
Tatsumi T; Kaiho T; Iwase T; Miura G; Shimizu D; Niizawa T; Ozawa Y; Arai M; Oshitari T; Takatsuna Y; Baba T
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792915
[No Abstract] [Full Text] [Related]
7. Real-world effects of anti-vascular endothelial growth factor injection frequency on visual outcomes in patients with diabetic macular oedema.
Payne CJ; Gupta U; Maatouk CM; Kuo BL; Perkins SW; Singh RP; Talcott KE
Eye (Lond); 2024 Jun; 38(9):1687-1693. PubMed ID: 38448732
[TBL] [Abstract][Full Text] [Related]
8. Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema.
Saima Y; Yokota H; Kushiyama A; Hanaguri J; Ohno A; Takase K; Sugiyama R; Muranaka K; Yamagami S; Nagaoka T
Sci Rep; 2024 Jun; 14(1):13798. PubMed ID: 38877041
[TBL] [Abstract][Full Text] [Related]
9. Transient regression of new vessels after anti-vascular endothelial growth factor monotherapy in proliferative diabetic retinopathy.
Venkatesh R; Anilkumar A; Mangla R; Sharief S; Chhablani J
Clin Exp Optom; 2024 Jul; 107(5):587-588. PubMed ID: 37078163
[No Abstract] [Full Text] [Related]
10. Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.
Antoszyk AN; Tarnowski KW; Basu K; Ehrlich JS; Haskova Z
Ophthalmol Retina; 2020 Oct; 4(10):1034-1036. PubMed ID: 32512056
[No Abstract] [Full Text] [Related]
11. Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T.
Cai S; Bressler NM
Curr Opin Ophthalmol; 2017 Nov; 28(6):636-643. PubMed ID: 28837425
[TBL] [Abstract][Full Text] [Related]
12. Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021.
Lindboe JB; Brynskov T; Sørensen TL; Schmidt Laugesen C
Acta Ophthalmol; 2024 Jun; 102(4):e661-e662. PubMed ID: 38525896
[No Abstract] [Full Text] [Related]
13. Intravitreal aflibercept for diabetic macular oedema: Moorfields' real-world 12-month visual acuity and anatomical outcomes.
Lukic M; Williams G; Shalchi Z; Sim D; Patel PJ; Keane PA; Hykin PG; Sivaprasad S; Menon D; Bruynseels A; Hamilton RD; Rajendram R
Eur J Ophthalmol; 2020 May; 30(3):557-562. PubMed ID: 30808179
[TBL] [Abstract][Full Text] [Related]
14. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience.
Parca O; Cetin EN
Indian J Ophthalmol; 2024 May; 72(Suppl 3):S453-S458. PubMed ID: 38648453
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]